Evidence map›Paper›PMID 42249218›Full record

Observational studyEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Predictors of treatment initiation in nontuberculous mycobacterial pulmonary disease: a real-life retrospective analysis.

Giovanni Fumagalli, Niccolò Riccardi, Marta Nadalin, Mariangela Puci, Lucia Allavena, Maurizio Ferrarese, Alice Repossi, Paola Faverio, Fabrizio Luppi, Giovanni Sotgiu and 1 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giovanni FumagalliTB Regional Reference Centre and Laboratory, ASST Grande Ospedale Metropolitano Niguarda-Villa Marelli Institute, Milan, Italy. giovanni.fumagalli@ospedaleniguarda.it.ORCID http://orcid.org/0009-0009-2092-7501
Niccolò RiccardiTB Regional Reference Centre and Laboratory, ASST Grande Ospedale Metropolitano Niguarda-Villa Marelli Institute, Milan, Italy.
Marta NadalinSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Mariangela PuciDepartment of Medical, Surgical and Experimental Sciences, Clinical Epidemiology and Medical Statistics Unit, University of Sassari, Sassari, Italy.
Lucia AllavenaTB Regional Reference Centre and Laboratory, ASST Grande Ospedale Metropolitano Niguarda-Villa Marelli Institute, Milan, Italy.
Maurizio FerrareseTB Regional Reference Centre and Laboratory, ASST Grande Ospedale Metropolitano Niguarda-Villa Marelli Institute, Milan, Italy.
Alice RepossiTB Regional Reference Centre and Laboratory, ASST Grande Ospedale Metropolitano Niguarda-Villa Marelli Institute, Milan, Italy.
Paola FaverioSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Fabrizio LuppiSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Giovanni SotgiuDepartment of Medical, Surgical and Experimental Sciences, Clinical Epidemiology and Medical Statistics Unit, University of Sassari, Sassari, Italy.
Luigi Ruffo CodecasaTB Regional Reference Centre and Laboratory, ASST Grande Ospedale Metropolitano Niguarda-Villa Marelli Institute, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nontuberculous mycobacterial pulmonary disease (NTM-PD) requires prolonged, complex antimicrobial therapy. Identifying predictors of treatment initiation in routine practice is crucial. We conducted a retrospective observational study of consecutive adults with NTM-PD evaluated at a tertiary referral center between 2021 and 2025. Demographic, clinical, radiological, and microbiological characteristics were compared between patients managed with observation and those who initiated treatment. Multivariate logistic regression identified independent predictors of treatment initiation. Among 317 patients, 176 initiated therapy and 141 were observed. Treatment initiation was independently associated with smear positivity, mixed or cavitary radiological patterns, systemic symptoms, particularly fever and weight loss, and immunosuppression. Airway clearance techniques and isolation of Mycobacterium abscessus were associated with a lower likelihood of treatment initiation. Respiratory symptoms did not influence treatment decision. These findings support current guideline recommendations and provide additional insight into the clinical aspects of the disease.

Indexed as

Anti-Bacterial AgentsLung DiseasesMycobacterium Infections, NontuberculousNontuberculous MycobacteriaAgedFemaleHumansMaleMiddle AgedMycobacterium abscessusRetrospective StudiesAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.